Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $636.73 billion, total revenue of $166.83 billion and a weighted average PE ratio of 35.68.
Market Cap
636.73B
Revenue
166.83B
Profits
17.84B
PE Ratio
35.68
Profit Margin
10.70%
Dividend Yield
0.26%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 174.82B | 0.51% | 1,176,899 | 45.20B |
| 2 | DHR | Danaher Corporation | 127.06B | -0.61% | 2,579,255 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.29B | -0.82% | 282,646 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.50B | -0.52% | 1,190,797 | 7.07B |
| 5 | WAT | Waters Corporation | 29.57B | 0.49% | 630,826 | 3.17B |
| 6 | NTRA | Natera, Inc. | 28.62B | -1.19% | 1,152,658 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 26.78B | -2.64% | 743,411 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.55B | -1.00% | 45,141 | 4.03B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.59B | -0.79% | 344,829 | 11.28B |
| 10 | LH | Labcorp Holdings Inc. | 21.40B | -1.15% | 398,829 | 13.95B |
| 11 | ILMN | Illumina, Inc. | 19.19B | -1.70% | 629,914 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 11.82B | -1.74% | 576,053 | 2.68B |
| 13 | GH | Guardant Health, Inc. | 10.87B | -6.33% | 1,760,552 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.55B | -1.62% | 566,493 | 2.86B |
| 15 | CRL | Charles River Laboratories International, Inc. | 8.16B | -3.38% | 257,837 | 4.02B |
| 16 | ICLR | ICON Public Limited Company | 7.74B | -1.85% | 1,101,164 | 8.10B |
| 17 | QGEN | Qiagen N.V. | 7.08B | -10.08% | 5,675,396 | 2.09B |
| 18 | RDNT | RadNet, Inc. | 4.46B | -1.39% | 321,126 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.40B | -2.40% | 1,089,819 | 1.16B |
| 20 | TWST | Twist Bioscience Corporation | 3.66B | -2.05% | 335,961 | 391.56M |
| 21 | BLLN | BillionToOne, Inc. | 3.57B | -5.17% | 277,610 | 305.11M |
| 22 | VCYT | Veracyte, Inc. | 2.66B | -1.03% | 287,528 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.16B | -4.14% | 245,270 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.95B | 0.74% | 202,135 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.15B | 2.90% | 1,651,502 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 1.14B | 1.60% | 327,796 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 922.27M | 1.25% | 692,107 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 744.67M | -1.60% | 116,267 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 570.49M | -8.56% | 1,562,922 | 69.65M |
| 30 | MYGN | Myriad Genetics, Inc. | 459.47M | 0.72% | 379,290 | 824.50M |
| 31 | FLGT | Fulgent Genetics, Inc. | 439.30M | -2.37% | 251,533 | 322.67M |
| 32 | PRE | Prenetics Global Limited | 311.41M | -5.68% | 139,545 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 181.63M | -11.49% | 30,047 | 77.14M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 136.07M | 10.16% | 311,719 | 4.06M |
| 35 | FONR | FONAR Corporation | 123.74M | 0.08% | 46,011 | 106.03M |
| 36 | MDXH | MDxHealth SA | 104.78M | - | 74,514 | 107.88M |
| 37 | BDSX | Biodesix, Inc. | 102.54M | 0.20% | 21,099 | 88.50M |
| 38 | XGN | Exagen Inc. | 65.30M | -0.91% | 63,836 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 57.52M | 5.05% | 81,771 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 12.22M | 23.08% | 2,605,691 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 10.42M | -5.92% | 66,175 | - |
| 42 | NOTV | Inotiv, Inc. | 10.12M | 1.00% | 256,708 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 9.27M | -1.68% | 15,680 | 29.21M |
| 44 | ADVB | Advanced Biomed Inc. | 7.17M | -0.85% | 4,697 | - |
| 45 | QUCY | Mainz Biomed N.V. | 6.57M | -2.74% | 148,730 | 537.08K |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.79M | -3.11% | 4,285 | - |
| 47 | ISPC | iSpecimen Inc. | 3.39M | -7.11% | 274,298 | 1.93M |